Related Experiment Video

Updated: Jun 24, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[Heart failure in diabetes]

Michael Resl1, Martin Hülsmann, Richard Pacher

  • 1Klinische Abteilung für Endokrinologie und Stoffwechsel, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Austria.

Wiener Medizinische Wochenschrift (1946)
|April 4, 2009
PubMed

Insights

This study highlights the strong link between glucose metabolism and chronic heart failure, particularly how elevated HbA1c levels increase heart failure risk. Diabetic cardiomyopathy arises from diabetes complications affecting cardiac function and calcium handling.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Context:

  • Epidemiologic studies confirm interactions between glucose metabolism and chronic heart failure.
  • Elevated HbA1c is associated with increased heart failure risk, underscoring the disease connection.
  • Diabetic heart failure results from long-term diabetes mellitus complications like coronary artery disease, hypertension, and diabetic cardiomyopathy.

Purpose:

  • To elucidate the mechanisms underlying diabetic cardiomyopathy and its contribution to heart failure.
  • To explore the role of specific molecular and systemic dysfunctions in diabetic heart failure.
  • To review diagnostic methods and current treatment recommendations for diabetic heart failure.

Summary:

  • Diabetic cardiomyopathy involves dysfunction in cardiac calcium handling due to reduced Na-Ca exchanger and SERCA2a protein expression.
  • An overactive renin-angiotensin-aldosterone system (RAAS) further impairs myocardial function.
  • Hyperlipidemia, hyperinsulinemia, and hyperglycemia are direct triggers of diabetic cardiomyopathy.

Impact:

  • Understanding these interactions is crucial for managing patients with both diabetes and heart failure.
  • This review synthesizes current knowledge on diabetic cardiomyopathy, aiding clinical practice.
  • Highlights the need for tailored treatment strategies based on subgroup analyses of heart failure trials.

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

Related Concept Videos

Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...